Impact of Momordica charantia (karela) on serum alanine aminotransferase level in streptozotocin induced diabetic rats

Authors

  • S Mohal Professor, Department of Anatomy, MH Samorita Medical College, Dhaka
  • DK Mondal Professor, Department of Anatomy, Gazi Medical College, Khulna
  • PK Chowdhury Assistant Professor, Respiratory Medicine, Khulna Medical College, Khulna
  • H Biswas Associate Professor, Department of Forensic Medicine, Diabetic Association Medical College, Faridpur
  • A Khanom Assistant Professor, Department of Gynae Onchology, National Cancer Research Institute & Hospital, Dhaka
  • KM Shamim Professor, Department of Anatomy, Bangabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/mediscope.v1i1.21634

Keywords:

Diabetes mellitus, Serum alanine aminotransferase, Momordica charantia (karela)

Abstract

The present experimental study was conducted at Department of Anatomy in BSMMU (Bangabandhu Sheikh Mujib Medical University) & BIRDEM (Bangladesh Institute of Research & rehabilitation in Diabetes, Endocrine & metabolic Disorders) to investigate whether Momordica charantia (karela) has got any impact on serum alanine aminotransferase (ALT) level in the streptozotocin-induced diabetic rats. Sixty healthy young Long Evans rats of male sex weighing 150 to 280 gm aged between 10 to 12 weeks were used in this study. The rats were divided into 4 equal groups depending on their different sorts of dietary feedings and drug treatment. The final ALT level (on 51st day) ranged from 23 to 34 u/L (mean 30.10 u/L) in healthy rats, 56 to 80 u/L (mean 68.50 u/L) in the untreated diabetic rats, 36 o 37 u/L (mean 31.50 u/L) in the insulin-treated diabetic rats and 61 to 96 u/L (mean 81.10 u/L) in the karela-treated diabetic rats. The ALT percentage change value of diabetic rats on 51st day corresponding to the initial on 7th day was significantly higher than that healthy rats (p<0.001). The value in the insulin-treated diabetic rats was significantly lower than that of the untreated diabetic rats (p<0.001) & the karela-treated diabetic rats (p<0.001). There was no significant difference between the values of the untreated diabetic rats & the karela-treated diabetic rats (p>0.05). The present study did not show that karela has any significant impact of acting against higher serum ALT level in streptozotocin-induced diabetes mellitus. Further investigation is recommended for establishing karela as an agent against higher serum ALT level in diabetes mellitus.

DOI: http://dx.doi.org/10.3329/mediscope.v1i1.21634

Mediscope Vol. 1, No. 1: 2014, Pages 29-32

Downloads

Download data is not yet available.
Abstract
132
PDF
88

Downloads

Published

2015-01-15

How to Cite

Mohal, S., Mondal, D., Chowdhury, P., Biswas, H., Khanom, A., & Shamim, K. (2015). Impact of Momordica charantia (karela) on serum alanine aminotransferase level in streptozotocin induced diabetic rats. Mediscope, 1(1), 29–32. https://doi.org/10.3329/mediscope.v1i1.21634

Issue

Vol. 1 No. 1 (2014)

Section

Original Articles

License

Authors who publish in the Mediscope agree to the following terms that:

  1. Authors retain copyright and grant Mediscope the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Mediscope are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  1. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  2. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.